advertisement
Advances in Therapy 28
Showing records 1 to 25 | Display all abstracts in Advances in Therapy73067 Prospective Observational Post-Marketing Study of Tafluprost for Glaucoma and Ocular Hypertension: Effectiveness and Treatment Persistence
Kuwayama Y
Advances in Therapy 2017; 34: 1411-1425
73277 Resource Utilization Among Glaucoma Patients in the UK Treated with Beta-Blocker and Non-Beta-Blocker Adjunctive Therapy: A Retrospective Cohort Analysis
Viswanathan A
Advances in Therapy 2017; 34: 1695-1706
72730 Targeting Schlemm's Canal in the Medical Therapy of Glaucoma: Current and Future Considerations
Andrés-Guerrero V
Advances in Therapy 2017; 34: 1049-1069
73076 Multicenter, Randomized, Investigator-Masked Study Comparing Brimonidine Tartrate 0.1% and Timolol Maleate 0.5% as Adjunctive Therapies to Prostaglandin Analogues in Normal-Tension Glaucoma
Mizoue S
Advances in Therapy 2017; 34: 1438-1448
73496 Prescribing Trends in a Glaucoma Clinic and Adherence to EGS Guidelines: A Retrospective, Non-Interventional, Single-Center UK Study
Fajgenbaum M
Advances in Therapy 2017; 34: 2033-2042
72620 A Review of the Ahmed Glaucoma Valve Implant and Comparison with Other Surgical Operations
Riva I
Advances in Therapy 2017; 34: 834-847
73496 Prescribing Trends in a Glaucoma Clinic and Adherence to EGS Guidelines: A Retrospective, Non-Interventional, Single-Center UK Study
Ansari E
Advances in Therapy 2017; 34: 2033-2042
73067 Prospective Observational Post-Marketing Study of Tafluprost for Glaucoma and Ocular Hypertension: Effectiveness and Treatment Persistence
Hashimoto M
Advances in Therapy 2017; 34: 1411-1425
73277 Resource Utilization Among Glaucoma Patients in the UK Treated with Beta-Blocker and Non-Beta-Blocker Adjunctive Therapy: A Retrospective Cohort Analysis
Spera C
Advances in Therapy 2017; 34: 1695-1706
73076 Multicenter, Randomized, Investigator-Masked Study Comparing Brimonidine Tartrate 0.1% and Timolol Maleate 0.5% as Adjunctive Therapies to Prostaglandin Analogues in Normal-Tension Glaucoma
Nitta K
Advances in Therapy 2017; 34: 1438-1448
72620 A Review of the Ahmed Glaucoma Valve Implant and Comparison with Other Surgical Operations
Roberti G
Advances in Therapy 2017; 34: 834-847
72730 Targeting Schlemm's Canal in the Medical Therapy of Glaucoma: Current and Future Considerations
García-Feijoo J; Konstas AG
Advances in Therapy 2017; 34: 1049-1069
73067 Prospective Observational Post-Marketing Study of Tafluprost for Glaucoma and Ocular Hypertension: Effectiveness and Treatment Persistence
Kakegawa R
Advances in Therapy 2017; 34: 1411-1425
73277 Resource Utilization Among Glaucoma Patients in the UK Treated with Beta-Blocker and Non-Beta-Blocker Adjunctive Therapy: A Retrospective Cohort Analysis
Mullins A
Advances in Therapy 2017; 34: 1695-1706
72620 A Review of the Ahmed Glaucoma Valve Implant and Comparison with Other Surgical Operations
Katsanos A
Advances in Therapy 2017; 34: 834-847
73076 Multicenter, Randomized, Investigator-Masked Study Comparing Brimonidine Tartrate 0.1% and Timolol Maleate 0.5% as Adjunctive Therapies to Prostaglandin Analogues in Normal-Tension Glaucoma
Shirakashi M
Advances in Therapy 2017; 34: 1438-1448
72620 A Review of the Ahmed Glaucoma Valve Implant and Comparison with Other Surgical Operations
Oddone F
Advances in Therapy 2017; 34: 834-847
73076 Multicenter, Randomized, Investigator-Masked Study Comparing Brimonidine Tartrate 0.1% and Timolol Maleate 0.5% as Adjunctive Therapies to Prostaglandin Analogues in Normal-Tension Glaucoma
Nitta A
Advances in Therapy 2017; 34: 1438-1448
73277 Resource Utilization Among Glaucoma Patients in the UK Treated with Beta-Blocker and Non-Beta-Blocker Adjunctive Therapy: A Retrospective Cohort Analysis
Covert D
Advances in Therapy 2017; 34: 1695-1706
73067 Prospective Observational Post-Marketing Study of Tafluprost for Glaucoma and Ocular Hypertension: Effectiveness and Treatment Persistence
Nomura A; Shimada F
Advances in Therapy 2017; 34: 1411-1425
73076 Multicenter, Randomized, Investigator-Masked Study Comparing Brimonidine Tartrate 0.1% and Timolol Maleate 0.5% as Adjunctive Therapies to Prostaglandin Analogues in Normal-Tension Glaucoma
Yamabayashi S
Advances in Therapy 2017; 34: 1438-1448
72620 A Review of the Ahmed Glaucoma Valve Implant and Comparison with Other Surgical Operations
Quaranta L
Advances in Therapy 2017; 34: 834-847
73277 Resource Utilization Among Glaucoma Patients in the UK Treated with Beta-Blocker and Non-Beta-Blocker Adjunctive Therapy: A Retrospective Cohort Analysis
Banhazi J; McDwyer P
Advances in Therapy 2017; 34: 1695-1706
73076 Multicenter, Randomized, Investigator-Masked Study Comparing Brimonidine Tartrate 0.1% and Timolol Maleate 0.5% as Adjunctive Therapies to Prostaglandin Analogues in Normal-Tension Glaucoma
Kimura T
Advances in Therapy 2017; 34: 1438-1448
73277 Resource Utilization Among Glaucoma Patients in the UK Treated with Beta-Blocker and Non-Beta-Blocker Adjunctive Therapy: A Retrospective Cohort Analysis
Hudson E
Advances in Therapy 2017; 34: 1695-1706
